Peptide vaccination can lead to enhanced tumor growth through specific T-cell tolerance induction.
René E. M. Toes(Leiden University Medical Center), W. Martin Kast(University of Southern California), Rienk Offringa(German Cancer Research Center), Cornelis J.M. Melief(ISA Pharmaceuticals (Netherlands)), R. Blom(Leiden University)
Cited by 294
Related Papers
Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity
|Nature Medicine|1995|1.1k
The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes.
|The Journal of Immunology|1994|851
Vaccination with cytotoxic T lymphocyte epitope‐containing peptide protects against a tumor induced by human papillomavirus type 16‐transformed cells
|European Journal of Immunology|1993|840
Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin
|Journal of Clinical Investigation|2012|708